Cargando…

The Roles of prM-E Proteins in Historical and Epidemic Zika Virus-mediated Infection and Neurocytotoxicity

The Zika virus (ZIKV) was first isolated in Africa in 1947. It was shown to be a mild virus that had limited threat to humans. However, the resurgence of the ZIKV in the most recent Brazil outbreak surprised us because it causes severe human congenital and neurologic disorders including microcephaly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ge, Bos, Sandra, Tsetsarkin, Konstantin A., Pletnev, Alexander G., Desprès, Philippe, Gadea, Gilles, Zhao, Richard Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409645/ https://www.ncbi.nlm.nih.gov/pubmed/30769824 http://dx.doi.org/10.3390/v11020157

Ejemplares similares

Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development
por: Nambala, Peter, et al.
Publicado: (2018)

Probing Molecular Insights into Zika Virus–Host Interactions
por: Lee, Ina, et al.
Publicado: (2018)

Zika virus prM protein contains cholesterol binding motifs required for virus entry and assembly
por: Goellner, Sarah, et al.
Publicado: (2023)

The Envelope Residues E152/156/158 of Zika Virus Influence the Early Stages of Virus Infection in Human Cells
por: Bos, Sandra, et al.
Publicado: (2019)

C-Terminal Helical Domains of Dengue Virus Type 4 E Protein Affect the Expression/Stability of prM Protein and Conformation of prM and E Proteins
por: Tsai, Wen-Yang, et al.
Publicado: (2012)

The I22V and L72S substitutions in West Nile virus prM protein promote enhanced prM/E heterodimerisation and nucleocapsid incorporation
por: Setoh, Yin Xiang, et al.
Publicado: (2015)

An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens
por: Jin, Hongli, et al.
Publicado: (2021)

The Safe Baculovirus-Based PrM/E DNA Vaccine Protected Fetuses against Zika Virus in A129 Mice
por: Choi, Hanul, et al.
Publicado: (2021)

The prM-independent packaging of pseudotyped Japanese encephalitis virus
por: Lee, Hee Jung, et al.
Publicado: (2009)

Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein
por: Liu, Xinglong, et al.
Publicado: (2018)

Leu-to-Phe substitution at prM(146) decreases the growth ability of Zika virus and partially reduces its pathogenicity in mice
por: Inagaki, Takuya, et al.
Publicado: (2021)

Neuroinvasiveness of the MR766 strain of Zika virus in IFNAR(-/-) mice maps to prM residues conserved amongst African genotype viruses
por: Nakayama, Eri, et al.
Publicado: (2021)

The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection in Human Cells
por: Gaudry, Arnaud, et al.
Publicado: (2018)

Dengue Patients Exhibit Higher Levels of PrM and E Antibodies Than Their Asymptomatic Counterparts
por: Yeo, Adeline Syin Lian, et al.
Publicado: (2015)

A Viperin Mutant Bearing the K358R Substitution Lost its Anti-ZIKA Virus Activity
por: Vanwalscappel, Bénédicte, et al.
Publicado: (2019)

A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2016)

Dengue: a growing threat requiring vaccine development for disease prevention
por: Bos, Sandra, et al.
Publicado: (2018)

A Reverse Mutation E143K within the PrM Protein of Zika Virus Asian Lineage Natal RGN Strain Increases Infectivity and Cytopathicity
por: Lin, Chen-Sheng, et al.
Publicado: (2022)

Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM
por: Luo, Yayan, et al.
Publicado: (2015)

Mutation in West Nile Virus Structural Protein prM during Human Infection
por: Lustig, Yaniv, et al.
Publicado: (2016)

Flavivirus prM interacts with MDA5 and MAVS to inhibit RLR antiviral signaling
por: Sui, Liyan, et al.
Publicado: (2023)

A Human PrM Antibody That Recognizes a Novel Cryptic Epitope on Dengue E Glycoprotein
por: Chan, Annie Hoi Yi, et al.
Publicado: (2012)

Systematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM Protein
por: Nadugala, Mahesha N., et al.
Publicado: (2016)

Griffithsin binds to the glycosylated proteins (E and prM) of Japanese encephalitis virus and inhibit its infection
por: Ishag, Hassan Z.A., et al.
Publicado: (2016)

A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization
por: Frumence, Etienne, et al.
Publicado: (2019)

Development and biochemical characteristics of a monoclonal antibody against prM protein of Tembusu virus
por: Zhu, Siming, et al.
Publicado: (2023)

Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus
por: Higuchi, Akira, et al.
Publicado: (2016)

E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice
por: Tajima, Shigeru, et al.
Publicado: (2019)

Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling
por: Bos, Sandra, et al.
Publicado: (2020)

A GFP Reporter MR766-Based Flow Cytometry Neutralization Test for Rapid Detection of Zika Virus-Neutralizing Antibodies in Serum Specimens
por: Frumence, Etienne, et al.
Publicado: (2019)

Zika M Oligopeptide ZAMP Confers Cell Death-Promoting Capability to a Soluble Tumor-Associated Antigen through Caspase-3/7 Activation
por: Vanwalscappel, Bénédicte, et al.
Publicado: (2020)

Epididymal epithelium propels early sexual transmission of Zika virus in the absence of interferon signaling
por: Pletnev, Alexander G., et al.
Publicado: (2021)

Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins
por: Wang, Pei-Gang, et al.
Publicado: (2009)

Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus
por: El Kalamouni, Chaker, et al.
Publicado: (2018)

Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses.
por: Cardosa, Mary Jane, et al.
Publicado: (2002)

Increased Cleavage of Japanese Encephalitis Virus prM Protein Promotes Viral Replication but Attenuates Virulence
por: Xiong, Junyao, et al.
Publicado: (2022)

prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis
por: A. Dowd, Kimberly, et al.
Publicado: (2023)

Zika virus tropism during early infection of the testicular interstitium and its role in viral pathogenesis in the testes
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2020)

Recombinant Zika NS1 Protein Secreted from Vero Cells Is Efficient for Inducing Production of Immune Serum Directed against NS1 Dimer
por: Viranaicken, Wildriss, et al.
Publicado: (2017)

Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І
por: Qian, Ping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l7ftn1tsapp1se12c7thar6vda